Stallard N - Search Results

1

Recent advances in methodology for clinical trials in small populations: the InSPiRe project.

Friede T, Posch M, Zohar S, Alberti C, Benda N, Comets E, Day S, Dmitrienko A, Graf A, Günhan BK, Hee SW, Lentz F, Madan J, Miller F, Ondra T, Pearce M, Röver C, Toumazi A, Unkel S, Ursino M, Wassmer G, Stallard N. Friede T, et al. Among authors: stallard n. Orphanet J Rare Dis. 2018 Oct 25;13(1):186. doi: 10.1186/s13023-018-0919-y. Orphanet J Rare Dis. 2018. PMID: 30359266 Free PMC article. Review.

2

Designing a series of decision-theoretic phase II trials in a small population.

Hee SW, Stallard N. Hee SW, et al. Among authors: stallard n. Stat Med. 2012 Dec 30;31(30):4337-51. doi: 10.1002/sim.5573. Epub 2012 Aug 24. Stat Med. 2012. PMID: 22927289

3

Decision-theoretic designs for small trials and pilot studies: A review.

Hee SW, Hamborg T, Day S, Madan J, Miller F, Posch M, Zohar S, Stallard N. Hee SW, et al. Among authors: stallard n. Stat Methods Med Res. 2016 Jun;25(3):1022-38. doi: 10.1177/0962280215588245. Epub 2015 Jun 5. Stat Methods Med Res. 2016. PMID: 26048902 Free PMC article. Review.

4

Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review.

Ondra T, Dmitrienko A, Friede T, Graf A, Miller F, Stallard N, Posch M. Ondra T, et al. Among authors: stallard n. J Biopharm Stat. 2016;26(1):99-119. doi: 10.1080/10543406.2015.1092034. J Biopharm Stat. 2016. PMID: 26378339 Free PMC article. Review.

5

Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.

Unkel S, Röver C, Stallard N, Benda N, Posch M, Zohar S, Friede T. Unkel S, et al. Among authors: stallard n. Orphanet J Rare Dis. 2016 Feb 20;11:16. doi: 10.1186/s13023-016-0402-6. Orphanet J Rare Dis. 2016. PMID: 26897367 Free PMC article. Review.

6

Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov.

Hee SW, Willis A, Tudur Smith C, Day S, Miller F, Madan J, Posch M, Zohar S, Stallard N. Hee SW, et al. Among authors: stallard n. Orphanet J Rare Dis. 2017 Mar 2;12(1):44. doi: 10.1186/s13023-017-0597-1. Orphanet J Rare Dis. 2017. PMID: 28253932 Free PMC article.

7

Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations.

Ursino M, Zohar S, Lentz F, Alberti C, Friede T, Stallard N, Comets E. Ursino M, et al. Among authors: stallard n. Biom J. 2017 Jul;59(4):804-825. doi: 10.1002/bimj.201600084. Epub 2017 Mar 21. Biom J. 2017. PMID: 28321893 Free PMC article.

8

Approaches to sample size calculation for clinical trials in rare diseases.

Miller F, Zohar S, Stallard N, Madan J, Posch M, Hee SW, Pearce M, Vågerö M, Day S. Miller F, et al. Among authors: stallard n. Pharm Stat. 2018 May;17(3):214-230. doi: 10.1002/pst.1848. Epub 2018 Jan 10. Pharm Stat. 2018. PMID: 29322632

9

Value of information methods to design a clinical trial in a small population to optimise a health economic utility function.

Pearce M, Hee SW, Madan J, Posch M, Day S, Miller F, Zohar S, Stallard N. Pearce M, et al. Among authors: stallard n. BMC Med Res Methodol. 2018 Feb 8;18(1):20. doi: 10.1186/s12874-018-0475-0. BMC Med Res Methodol. 2018. PMID: 29422021 Free PMC article.

10

Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges.

Ursino M, Stallard N. Ursino M, et al. Among authors: stallard n. Int J Environ Res Public Health. 2021 Jan 24;18(3):1022. doi: 10.3390/ijerph18031022. Int J Environ Res Public Health. 2021. PMID: 33498915 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page